Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer

• Published in: Frontiers in oncology 2023-05, Vol.13, p.999193-999193
• Main Authors: Luo, Hongwei, Zhang, Que, Liu, Xiangchu, Luo, Yue, Jiang, Xing, Wang, Chao, Chen, Bin, He, Qiming, Zhang, Yingchun, Shu, Ou, Dai, Penggao, He, Chengcheng
• Format: Article
• Language: English
• Subjects: colon cancer; cuproptosis; gene signature; immunity therapy; molecular subtyping; Oncology; tumor microenvironment
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2023.999193

Colon cancer is one of the common cancers, and its prognosis remains to be improved. The role of cuproptosis as a newly discovered form of cell death in the development of colon cancer has not been determined. Based on 983 colon cancer samples in the TCGA database and the GEO database, we performed a comprehensive genomic analysis to explore the molecular subtypes mediated by cuproptosis-related genes. Single-sample gene set enrichment analysis (ssGSEA) was utilized to quantify the relative abundance of each cell infiltrate in the TME. A risk score was established using least absolute shrinkage and selection operator regression (LASSO), and its predictive ability for colon cancer patients was verified to explore its guiding value for treatment. We identified two distinct cuproptosis-related molecular subtypes in colon cancer. These two distinct molecular subtypes can predict clinicopathological features, prognosis, TME activity, and immune-infiltrating cells. A risk model was developed and its predictive ability was verified. Compared with patients in the high-risk score group, patients in the low-risk score group were characterized by lower tumor microenvironment score, higher stem cell activity, lower tumor mutational burden, lower microsatellite instability, higher sensitivity to chemotherapeutics, and better immunotherapy efficacy. This study contributes to understanding the molecular characteristics of cuproptosis-related subtypes. We demonstrate a critical role for cuproptosis genes in colon cancer s in the TME. Our study contributes to the development of individualized treatment regimens for colon cancer.